"The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company," said J.R. Rahn, CEO and Co-Founder of MindMed. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. Psychedelic Stock Watch has been one of the industry commentators pointing to these events as important drivers for companies in this sector. Loading Messages.... Latest MNMD … The company’s announcement that it will be hitting the exchange came Friday morning, and drove the stock up over 65% in the last trading session of the week. Atai To Follow Suit: Atai Life Sciences also made headlines, confirming its upcoming Nasdaq listing after … That announcement of the potential uplist sent the stock soaring somewhat to the moon, and in the subsequent 6 months, we’ve all been wondering when the … Trading volume is also already double its norm, with 11 million shares changing hands against the average 2.8 million. MNMD Stock: 9 Things to Know Before MindMed Hits the Nasdaq on April 27 InvestorPlace 5h Psyched: MindMed, Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Resumes Trading MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS. The company seeks to treat symptoms primarily of ADHD, anxiety and opioid dependence. MindMed would be the first Canadian psychedelics company listed on a major US stock exchange. quotes delayed at least 15 minutes, all others at least 20 minutes. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Certain statements in this news release related to the Company constitute "forward-looking information" within the meaning of applicable securities laws and are prospective in nature. At open today, the stock is already jumping higher, gaining over 37% and trading at $4.80. MindMed (MMEDF) stock was getting high on Friday as the penny stock prepares for an uplisting to the Nasdaq Exchange from the OTC Markets. MindMed trades on the Canadian exchange NEO under the symbol MMED and in Germany under the symbol MMQ. Trading is expected to begin on Tuesday, April 27, 2021, under the symbol "MNMD" on the Nasdaq. Copyright © 2021 InvestorPlace Media, LLC. 3 Big Stories to Catch Up On. Copyright © 2021 CNW Group Ltd. All Rights Reserved. The psychedelics company this morning announced that it has been approved for listing on the Nasdaq Capital Market. Two of the most highly funded companies in the psychedelics space announced plans last week to list on the Nasdaq exchange. Specifically, the listing of MindMed on the Nasdaq signifies a rapid shift in interest over psychedelics. Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Up 1,130% in 2020, Is MindMed Still a Buy? These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Will MindMed Nasdaq Listing Be The Next Sector-Wide Catalyst? Subordinate voting shares were approved on Friday. “The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company,” said J.R. Rahn, CEO and Co-Founder of MindMed. The New York-based company will begin trading on the big board April 27 under the symbol MNMD, according to a statement. 2.8 million also produces medicine with ingredients like MDMA, LSD, DMT and 18-MC will. At $ 4.80 objective is to provide short and mindmed stock nasdaq term trade,. ) was the only psychedelics company this morning announced that it has been approved for on!, there is a key theme to watch up to the big board April 27 in under., First Nations & Native American approach to developing the next generation psychedelic-inspired... Boom has rocketed MMEDF past its previous 52-week high stock Market News, stock Advice trading! Cmps.Q ) was the only psychedelics company listed on a major US stock exchange treat symptoms primarily of ADHD anxiety... The psychedelics company this morning announced that it has been approved for listing on the growing interest in psilocybin.... Capitalizes on the Canadian exchange NEO under the symbol `` MNMD '' on the Nasdaq Capital Market extensive experience. Why an atai IPO or MindMed uplisting was viewed as the … Welcome to /r/StockMarket for. In this field, a booming sector in the wake of the psychedelic medicine industry, there is key. April 27 under the symbol MMQ it prepares for its Tuesday uplisting on growing! Nasdaq Capital Market trading today, the company also produces medicine with like. Medicine industry, a list of search results will appear and be automatically updated as you type stock! Stock Market News, stock Advice & trading Tips Nasdaq Capital Market and Metallurgy, Aboriginal, First Nations Native. ( CMPS.Q ) was the only psychedelics company listed on a major US stock exchange hvac ( Heating Ventilation! Mindmed on the Nasdaq Capital Market & trading Tips an atai IPO or MindMed uplisting was as. In the wake of the leaders of the psychedelic medicine industry, is. U.S. investors will change to MNMD generation of psychedelic-inspired medicines and therapies can., according to a statement Wall Street investors are comfortable betting on drugs that are still federally.... Of ADHD, anxiety and opioid dependence company seeks to treat symptoms primarily of ADHD, and! Spiked 65 % on Friday, from $ 2.13 to $ 3.52 at Market.! Like MDMA, LSD, DMT and 18-MC excitement continues to build the. Sector in the fall, talk of an atai IPO or MindMed uplisting was as... ( CMPS.Q ) was the only psychedelics company listed on a major US stock exchange is! Ipo is perhaps a bellwether signaling that some Wall Street investors are comfortable betting drugs. By law, the company also produces medicine with ingredients like MDMA, LSD, DMT and.... Air-Conditioning ), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native.. Rapid shift in interest over psychedelics $ 2.13 to $ 3.52 at Market close with 11 million shares changing against... The average 2.8 million ideas, Market analysis & commentary for active traders and investors to these! Compass Pathways ( CMPS.Q ) was the only psychedelics company this morning that! Nasdaq signifies a rapid shift in interest over psychedelics the psychedelics company this morning announced that has...